Virgin Islanders who purchased certain generic prescription medications over a decade-long period have until Monday, November 9, to submit claims for potential compensation under two federal class-action settlements totaling $475 million, according to official settlement notices and court documents reviewed by the Consortium.
The settlements resolve allegations that pharmaceutical manufacturers engaged in anticompetitive conduct that artificially increased the prices of generic prescription drugs, causing consumers, insurers and other purchasers to pay more than they otherwise would have.
The U.S. Virgin Islands is specifically included among the jurisdictions whose qualifying consumers may receive compensation.
The claims deadline applies to two settlements approved by the U.S. District Court for the Eastern District of Pennsylvania: a $275 million agreement involving Sandoz Inc. and Fougera Pharmaceuticals Inc., and a separate $200 million agreement involving Sun Pharmaceutical Industries Inc. and Taro Pharmaceuticals U.S.A. Inc.
The manufacturers have denied liability. Their agreements resolve the claims against them but do not constitute findings that they engaged in the alleged misconduct. Litigation continues against defendants that have not settled.
Under the official settlement administrator's instructions, qualifying consumers must submit their claims online by November 9 or mail completed forms postmarked no later than that date.
The $475 million settlement total is not reserved exclusively for individual consumers. Eligible insurers and other third-party payers also have claims against the settlement funds.
Who Qualifies for Compensation?
The settlement classes cover individuals and other qualifying purchasers who indirectly purchased, paid for or reimbursed some or all of the cost of eligible generic prescription medications between May 1, 2009, and December 31, 2019.
The covered jurisdictions include 48 states, excluding Indiana and Ohio, as well as the District of Columbia, Puerto Rico and the U.S. Virgin Islands.
Virgin Islanders who paid out of pocket for eligible prescription drugs during that period, including through qualifying insurance copayments, may therefore be entitled to seek compensation.
However, not every prescription drug or purchase qualifies.
The official consumer claim form identifies several exclusions, including purchases covered by Medicaid, medications purchased directly from defendants, purchases made for resale, and individuals who previously opted out of the settlements.
Certain employees and affiliates of the defendants, along with judges assigned to the litigation and their immediate families, are also excluded.
Consumers who are uncertain about their eligibility can review the settlement criteria or contact the claims administrator.
Nearly 200 Generic Drug Categories Listed
The settlement's official drug list identifies 197 numbered categories covering hundreds of individual formulations and strengths.
Among the medications listed are certain formulations of albuterol, allopurinol, amitriptyline, doxycycline, levothyroxine, glimepiride, warfarin and extended-release metformin, along with numerous other prescription drugs.
The inclusion of a medication name does not necessarily mean every version or strength of that drug qualifies.
For example, the settlement identifies particular formulations of several commonly prescribed medications. Consumers must therefore verify that the medication they purchased matches the applicable entry.
The complete list is available in Appendix A of the official consumer claim form.
The settlement administrator also provides an online drug lookup tool to help consumers determine whether their medications are included.
Proof of Purchase Is Required
Consumers seeking compensation must identify each qualifying generic drug they purchased and provide the total amount they personally paid for that medication during the eligible period.
The administrator requires proof of at least one purchase for each medication included in the claim.
Acceptable documentation includes prescription receipts, invoices, account statements identifying the drug, or an itemized medication purchase history obtained from a pharmacy.
Other records may also qualify if they demonstrate that the consumer purchased the medication during the eligible period and identify the amount paid.
Consumers do not necessarily have to produce a separate receipt for every purchase made over the decade. However, they must provide documentation establishing at least one qualifying purchase of each drug claimed, and the administrator may request additional records to verify the amounts reported.
The claim form directs consumers to report their own out-of-pocket spending, rather than amounts paid by their insurance companies.
All information submitted must be accurate. The administrator can audit claims and reject those lacking sufficient documentation or containing unsupported amounts.
How Virgin Islanders Can File a Claim Today
The claims process is administered through the official website, GenericDrugsEndPayerSettlement.com.
Eligible consumers can complete the claim form electronically, upload supporting records and submit an electronic signature.
Once the online form has been submitted, a confirmation screen will appear that claimants can save for their records.
The administrator advises that partially completed online forms cannot be saved and completed later. Consumers should therefore gather their information and documentation before beginning the process.
The website also warns that some mobile users may experience technical difficulties and recommends using a desktop or laptop computer or another browser if necessary.
Consumers who prefer paper forms may download the official claim form and instructions and mail the completed documents to:
In re: Generic Pharmaceuticals Pricing Antitrust Litigation – End-Payer Settlement
c/o A.B. Data, Ltd.
P.O. Box 173118
Milwaukee, WI 53217
Mailed claims must be postmarked no later than Monday, November 9, 2026.
The settlement administrator has not specified an exact online closing hour in its published instructions, making it important for consumers to submit claims as early as possible rather than assume they can file until a particular time tonight.
Consumers can obtain assistance by calling 1-877-316-0171 or emailing [email protected].
There is no requirement to hire a claims recovery company or pay an intermediary to participate.
How Much Money Will Consumers Receive?
Although the settlements total $475 million, there is no guaranteed payment amount for any individual claimant.
Eligible consumers will receive a proportional share of available settlement funds based on the amount they spent on covered medications and the volume of valid claims received.
Settlement administration costs, attorney fees and other court-authorized expenses are deducted from the applicable funds before distribution.
That means a consumer who purchased an eligible medication may receive compensation, but the amount cannot be determined simply by looking at the overall settlement value.
The administrator also cautions that submitting a claim does not guarantee payment. Claims must be validated and approved before compensation can be distributed.
Approved claimants may select payment methods that include direct deposit, Zelle, PayPal, Venmo or a paper check, according to the official claim form.
